Revenio Group Oyj (REG1V):企業の財務・戦略的SWOT分析

◆英語タイトル:Revenio Group Oyj (REG1V) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME241719FSA
◆発行会社(調査会社):GlobalData
◆発行日:2020年12月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥28,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥42,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Revenio Group Oyj (REG1V) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Revenio Group Oyj (Revenio) is a provider of health tech screening devices that focus on ophthalmic diagnostic solutions. The company focuses on early detection of glaucoma, asthma, skin cancer and macular degeneration. The company’s major products include devices for detecting age-related eye diseases which include glaucoma, diabetic retinopathy, macular degeneration and cataracts. Revenio offers its products to ophthalmologists, opticians and optometrists. The company has operations in Europe, America, and Asia. Revenio is headquartered in Vantaa, Finland.

Revenio Group Oyj Key Recent Developments

Oct 22,2020: Revenio Group : Interim report, January 1 – September 30, 2020
Oct 21,2020: Revenio Group board of directors established a nomination and remuneration committee
Aug 06,2020: Revenio Group Corporation: Half-year financial report, January 1 – June 30, 2020
Apr 22,2020: Revenio Group : Interim report, January 1 – March 31, 2020
Mar 31,2020: Jouni Toijala appointed as the CEO of Revenio Group

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Revenio Group Oyj – Key Facts
Revenio Group Oyj – Key Employees
Revenio Group Oyj – Key Employee Biographies
Revenio Group Oyj – Major Products and Services
Revenio Group Oyj – History
Revenio Group Oyj – Company Statement
Revenio Group Oyj – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Revenio Group Oyj – Business Description
Geographical Segment: Finland
Performance
Geographical Segment: Other Europe
Performance
Geographical Segment: Others
Performance
R&D Overview
Revenio Group Oyj – Corporate Strategy
Revenio Group Oyj – SWOT Analysis
SWOT Analysis – Overview
Revenio Group Oyj – Strengths
Revenio Group Oyj – Weaknesses
Revenio Group Oyj – Opportunities
Revenio Group Oyj – Threats
Revenio Group Oyj – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Revenio Group Oyj, Medical Equipment, Deals By Year, 2014 to YTD 2020
Revenio Group Oyj, Medical Equipment, Deals By Type, 2014 to YTD 2020
Revenio Group Oyj, Recent Deals Summary
Section 5 – Company’s Recent Developments
Oct 22, 2020: Revenio Group : Interim report, January 1 – September 30, 2020
Oct 21, 2020: Revenio Group board of directors established a nomination and remuneration committee
Aug 06, 2020: Revenio Group Corporation: Half-year financial report, January 1 – June 30, 2020
Apr 22, 2020: Revenio Group : Interim report, January 1 – March 31, 2020
Mar 31, 2020: Jouni Toijala appointed as the CEO of Revenio Group
Nov 25, 2019: Revenio Group Corporation – Changes in management
Aug 15, 2019: Revenio Group : Half-year financial report
Apr 16, 2019: Revenio Group: Interim Report January 1- March 31, 2019
Apr 15, 2019: Revenio Group: Mikko Moilanen appointed as Revenio’s CEO
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Revenio Group Oyj, Key Facts
Revenio Group Oyj, Key Employees
Revenio Group Oyj, Key Employee Biographies
Revenio Group Oyj, Major Products and Services
Revenio Group Oyj, History
Revenio Group Oyj, Subsidiaries
Revenio Group Oyj, Key Competitors
Revenio Group Oyj, Ratios based on current share price
Revenio Group Oyj, Annual Ratios
Revenio Group Oyj, Annual Ratios (Cont...1)
Revenio Group Oyj, Annual Ratios (Cont...2)
Revenio Group Oyj, Interim Ratios
Revenio Group Oyj, Medical Equipment, Deals By Year, 2014 to YTD 2020
Revenio Group Oyj, Medical Equipment, Deals By Type, 2014 to YTD 2020
Revenio Group Oyj, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Revenio Group Oyj (REG1V):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eng Kah Corporation Berhad:戦略・SWOT・企業財務分析
    Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report Summary Eng Kah Corporation Berhad - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • SATT Conectus Alsace SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary SATT Conectus Alsace SAS (Conectus Alsace), a subsidiary of SATT Association, is a technology transfer service provider. The company offers services such as single entry point, well-defined research collaborations, technology transfers, accessible technology platforms, license approach, inde …
  • The Hartford Financial Services Group, Inc.:企業の戦略・SWOT・財務情報
    The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary The Hartford Financial Services Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Newfoundland Power Inc:企業の戦略的SWOT分析
    Newfoundland Power Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • XOMA Corp (XOMA):企業の財務・戦略的SWOT分析
    XOMA Corp (XOMA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Epic Sciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Epic Sciences Inc (Epic Sciences) focuses to develop novel diagnostics for personalized treatment of cancer. The company develops AR-V7 test to identify and molecularly characterize circulating tumor cells in a blood sample. It also offers biopharma solutions such as resistance to AR signali …
  • Monogram Biosciences Inc:企業の戦略的SWOT分析
    Monogram Biosciences Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Bill Barrett Corp Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on …
  • Zeltiq Aesthetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Zeltiq Aesthetics Inc (Zeltiq), formerly Juniper Medical Inc, a subsidiary of Allergan Plc, is a medical technology company that develops and commercializes non-invasive products for the reduction of fat, selectively. The company offers CoolSculpting system, which uses proprietary controlled …
  • Duke Energy Corporation (DUK)-石油・ガス分野:企業M&A・提携分析
    Summary Duke Energy Corporation (Duke Energy) is an integrated energy utility that undertakes the generation, transmission, distribution and sale of electricity; transportation and sale of natural gas; and provision of related energy services in the Southeast and Midwest regions of the US. It also p …
  • New Age Metals Inc:企業の戦略・SWOT・財務情報
    New Age Metals Inc - Strategy, SWOT and Corporate Finance Report Summary New Age Metals Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • meteocontrol GmbH:電力:M&Aディール及び事業提携情報
    Summary Meteocontrol GmbH (meteocontrol) a subsidiary of S.A.G. Solar GmbH & Co. KG, is a renewable energy company which offers photovoltaic monitoring solutions. The company's product portfolio includes data loggers, WEB'logs, portals, sensor system, grid feed-in management or power control, SCADA …
  • China Pacific Insurance (Group) Co Ltd:戦略・SWOT・企業財務分析
    China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Pacific Insurance (Group) Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Corona Remedies Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Corona Remedies Pvt Ltd (Corona) is a drugs manufacturing company that develops, manufactures, and markets pharmaceutical products. The company’s products include antiallergic drugs, antibiotic drugs, analgesic drugs, antimalarial drugs, heamatonics, hormonal drugs, nutritional supplements, …
  • Edison International (EIX)-エネルギー分野:企業M&A・提携分析
    Summary Edison International (Edison) is an energy holding company. The company generates and distributes electric power; and invests in energy services and technologies, including renewable power, through its subsidiaries. It develops solar products and carries out commercial rooftop installation o …
  • Royal Mail plc (RMG):企業の財務・戦略的SWOT分析
    Royal Mail plc (RMG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • J&P – Avax Sa
    J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report Summary J&P - Avax Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Centrexion Therapeutics Corp (CNTX):製薬・医療:M&Aディール及び事業提携情報
    Summary Centrexion Therapeutics Corp (Centrexion Therapeutics), formerly Centrexion Corp is a developer of clinical pipelines of novel and non opioid chronic pain therapy products. The company offers products such as CNTX-4975, CNTX- 0290, CNTX-6970, CNTX-2022, CNTX-6016 and Intrathecalplatform. Its …
  • Red Hat Inc:企業の戦略的SWOT分析
    Red Hat Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • One Way Liver SL-医療機器分野:企業M&A・提携分析
    Summary One Way Liver SL (OWL), formerly One Way Liver Genomics SL is a biotechnology company that discovers, develops and offers diagnostic products and metabolomics services for the healthcare sector. The company commercializes OWLiver, which is a serum based test used for steatosis and NASH diagn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆